Bone metabolism in periand postmenopausal women with type 1 diabetes mellitus


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Aim. To estimate the effect of type 1 diabetes mellitus on bone mineral density and bone metabolism parameters in women; determ ine the direction of changes in serum bone remodeling markers and BMD in the peri- and post-menopausal women with this disease. Material and methods. The study comprised 57peri- and post-menopausal women with type 1diabetes (study group) and 43 women in the control group. Diagnostic evaluation included analysis of BMD using DXA and expressed as T-score, and serum bone remodeling markers (ALP, P1NP and b-CTx). Results. The findings showed the inconsistency of changes in bone remodeling in patients with type 1 diabetes mellitus (35.5% and 16.6%, p <0.001) with a predominant change in bone formation. The duration of diabetes had a positive correlation with serum b-CTXconcentration (r = 0.349, p = 0.008). A negative correlation was found between the change in T-score at the lumbar spine and the duration of diabetes (r = -0.239, p = 0.03). There was a statistically signif icant correlation between T-score at the lumbar spine and serum b-CTX level (r = -0.452, p = 0.002). Conclusion. The findings of this study suggest that changes in bone metabolism in the majority of patients are associated with bone formation inhibition and, to a much lesser extent, bone resorption accelerating during the late perimenopause, continuing at similar rates in the early years of postmenopause, and decreasing bone loss later.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Sain Safarova

Azerbaijan Medical University

Email: sainsafarova@gmail.com
MD, associate professor of the Department of Internal Diseases III, medical-prophylactic faculty II

Әдебиет тізімі

  1. Vestergaard P., Rejnmark L., Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif. Tissue Int. 2009; 84(1): 45-55.
  2. Pramojanee S.N., Phimphilai M., Chattipakorn N., Chattipakorn S.C. Possible roles of insulin signaling in osteoblasts. Endocr. Res. 2014; 39(4): 144-51.
  3. Соловьёва-Савоярова Г.Е., Дрожжина В.А. Эстрогены и некариозные поражения зубов. СПб.: СЗГМУ им. И.И. Мечникова; 2012.
  4. Farr J.N., Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016; 82: 28-34.
  5. Hough FS., Pierroz D.D., Cooper C., Ferrari S.L.; IOF CSA Bone and Diabetes Working Group. Mechanisms in endocrinology: mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur. J. Endocrinol. 2016; 174(4): R127-38.
  6. AL-Hariri M. Sweet bones: the pathogenesis of bone alteration in diabetes. J. Diabetes Res. 2016; 2016: ID 6969040.
  7. Starup-Linde J., Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - a systematic review. Bone. 2016; 82: 69-78.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>